This issue of The Journal of Pharmacokinetics and Pharmacodynamics (JPKPD) brings several changes. The Commentary from the leaders of the American Society of Pharmacometrics indicates that JPKPD will now serve as an official publication of this relatively new and energetic scientific group. Its members (including me) have been long-time supporters of the Journal and we look forward to JPKPD continuing to be a forum for not only innovative pharmacokinetic and pharmacodynamic modeling efforts, but also showcasing a growing array of pharmacometric and quantitative and systems pharmacology contributions to the literature. We are pleased to welcome Peter Bonate as a new Associate Editor and representative of ASoP. His knowledge and experience will be invaluable in dealing with the increasing complexity in use of mathematics, statistics, and software engineering to describe the myriad properties of drugs interacting with physiological systems.
Suk-Jae Chung, from the College of Pharmacy, Seoul National University, Korea, joined us as an Associate Editor at the beginning of 2011 to help maintain our visibility as a forum for contributions from throughout the world. William F. Elmquist, who has served as Associate Editor since 1998, is stepping down, joining our list of distinguished Emeritus Editors. We thank him for his many years of great service.
Finally, you will notice some changes in format of JPKPD, particularly the increase in page sizes and use of double columns. This matches the appearance of the majority of scientific journals. This will also help us accommodate an increased number of articles per issue. Your contributions and attention are most welcomed in helping to maintain JPKPD as the premier site for publication of theoretical and applied research relevant to diverse drugs and biotech products.
